"The Apple Watch Is Evolving Into A Legitimate Medical Device" -Claire Maldarelli
Apple is becoming the first wearable to delve deep into the medical sphere: The company gained FDA clearance to use its sensor and accompanying app to detect atrial fibrillation, or A-fib, an irregular heart rhythm that can lead to a variety of heart conditions including blood clots, stroke, and heart failure. “I think many health systems and medical device companies of the world have always believed that these tech companies have been too afraid to move into regulated healthcare space,” said Joel Dudley, PhD, director of the Institute for Next Generation Healthcare at the Icahn School of Medicine at Mount Sinai. “But I think this proves otherwise, that Apple is more than willing to engage with the FDA. It’s one of the most striking and aggressive examples to date of tech companies starting to eat their way into healthcare.”
- Joel Dudley, PhD, Director, Institute for Next Generation Healthcare, Associate Professor, Genetics and Genomic Sciences, Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, Executive Vice President, Precision Health, Mount Sinai Health System
Integrated, Multi-“omic” Studies of Asthma Could Lead to Precision Treatment
Jul 02, 2019 View All Press Releases
Mount Sinai and IBM Researchers Uncover Key to Greater Efficacy in Cancer Treatment
Mar 21, 2019 View All Press ReleasesNeurodegenerative Diseases Identified Using Artificial Intelligence
Mar 04, 2019 View All Press Releases